Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Sodium Thiosulfate for Ectopic Calcifications or Ossifications (Pilot Study)
2024-511620-13-00Phase 2Authorised
- Sponsor
- CHU de Limoges
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sodium thiosulfate in dermatomyositis (DM), systemic sclerosis (SSc) and Inactivating PTH/PTHrP signaling disorder type 2 (iPPSD2) (3 arms), sponsored by CHU de Limoges. Planned start Mar 2024; status: authorised.
02
Drugs
sodium thiosulfate
03
Conditions
dermatomyositis (DM)systemic sclerosis (SSc)Inactivating PTH/PTHrP signaling disorder type 2 (iPPSD2)
Beyond the preview
Go deeper on 2024-511620-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511620-13-00.